Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
NHS to benefit from £20.5 billion funding boost over the next 5 years
The Prime Minister has announced that the NHS will receive increased funding of £20.5 billion per year by the end of five years
The role of collaboration in tackling paediatric cancer
Prof. Martin Schrappe, President of the European Society for Paediatric Oncology details the vital role of collaboration in tackling paediatric cancer across Europe
Turning health data into knowledge to improve lives
Amanda White, Director of Communications and Marketing at Health Data Research UK, reflects on the opportunities to harness the UK’s strengths in data science to transform health
The current status of tuberculosis vaccine development
Helen McShane, Professor of Vaccinology at The Jenner Institute, University of Oxford reveals the current status of tuberculosis vaccine development in the world today.
Cannabis: One of the most thoroughly studied plants ever
David Bearman, M.D., Executive VP of the American Academy of Cannabinoid Medicine details the research priorities for cannabis, one of the most thoroughly studied plants of all time
The key issues around muscular dystrophy (MD) in Europe
Boris Šustaršič, President of the European Alliance of Neuromuscular Disorders Associations shares his thoughts on the key issues around muscular dystrophy (MD) in Europe today
An update on exports in the health technology sector
Jonathan Evans, communications manager at the Association of British HealthTech Industries provides an interesting update on the health technology sector, including the extent to which the UK exports to the EU every year in this vein.
Nanomedicines: Depicting human health risks hindering clinical translation
Cecilia Van Cauwenberghe from Frost & Sullivan shares her expertise on the world of nanomedicines, with a special focus on depicting human health risks hindering clinical translation.
How developmental biology changes our lives
Shyh-Jye Lee (Jeff), Ph. D, President of the Taiwanese Society of Developmental Biology (TSDB) explains the way in which developmental biology impacts upon our lives
Muscular dystrophy: Present concerns and foreseen opportunities
Cecilia Van Cauwenberghe from the TechVision Group at Frost & Sullivan provides a detailed analysis of the present concerns and foreseen opportunities around muscular dystrophy (MD)
Mental health care and the pharmaceutical industry
Marcin Rodzinka, Project Coordinator at Mental Health Europe explains how transparency between the pharma industry and health professionals can influence the quality of mental health care in Europe today
The challenge of curing cancer in the world’s children
Dr Martin English, Consultant Paediatric Oncologist and member of the Royal College of Paediatrics and Child Health (RCPCH) explains the challenge of curing cancer in the world’s children
What next for children and young people with speech, language and communication needs?
Mary Hartshorne, I CAN’s Head of Evidence shares her thoughts on the report Bercow: Ten Years On and the next steps for children and young people with speech, language and communication needs
The challenge of commercialisation: Keeping an academic balance
Prof Colin J Suckling OBE DSc FRSE, research professor of chemistry at the University of Strathclyde’s Department of Pure & Applied Chemistry shares his views on the challenge of commercialisation when it comes to research into medicinal chemistry
Sources of funding in the development of therapies for Huntington’s disease
Leora Fox, Jennifer Simpson and George Yohrling from the Huntington’s Disease Society of America explore the sources of funding in the development of therapies for Huntington’s disease (HD).
Tackling the root cause of Type 2 diabetes: Obesity
Kristoffer From, CEO of Liva Healthcare and Simon Pickup, UK Managing Director at Liva Healthcare share their thoughts on why obesity is key to tackling the root cause of Type 2 diabetes
Disease-associated myosteatosis in people with cancer: Can it be treated?
Can we prevent the muscle loss associated with some cancers? Dr Vera Mazurak at the University of Alberta is looking into one method of...
World No Tobacco Day: The effects on your heart
Many people don’t realise the harm that tobacco use does to the heart, a leading cardiologist has warned
Asthma sufferers willing to share data to improve care and research
A recent report from Asthma UK has shown that nine in ten people (88%), living with asthma in England are in favour of sharing their data to improve NHS services
2019 European elections: it is time to show that the voices of all EU...
As the European Parliament marks one year until the 2019 European elections, Mental Health Europe says EU states must reform outdated laws to show once and for all that people with psychosocial disabilities have a right to be heard
